July 2018

Rapid molecular methods in clinical microbiology

Microbiologist Mark Wilks highlights the potential rapid molecular methods presented in the recent conference of the British Society for Microbial Technology.

Fast molecular diagnostics for tight turnaround times

Turnaround times for diagnostic tests can be an obstacle to effectively controlling healthcare associated infections (HAI), such as methicillin-resistant Staphylococcus aureus (MRSA) and carbapenemase producing Enterobacteriaceae (CPE), with delayed results leading to ward closures and cancelled operations.

Biomedical Science Day 2018

Biomedical Science Day takes place on July 19 and the IBMS is calling on its members to join this celebration of the profession #AtTheHeartOfHealthcare, and the incredible hard work and dedication of biomedical scientists.

Clinical chemistry classics: tumour markers

This short series continues with a brief review of pioneering work in the development and clinical application of two important tumour markers – serum alpha fetoprotein and urine and serum human chorionic gonadotropin.

The progress of histopathology reporting

Jo Horne, Andrew Usher and Gerry van Schalkwyk discuss the progress of the histopathology reporting programme and look to the future.

The new dawn of immunotherapy

Steven Rosenberg made headlines around the globe for a breakthrough that could make immunotherapy a frontline cancer treatment.

The Big Question: "Does healthcare really need a 24/7 pathology service?"

Does healthcare really need a 24/7 pathology service?

Could bacteriophages replace antibiotics?

A small-scale preliminary trial concludes that bacteriophages could be a viable replacement for antibiotics in the future.

Editorial: Stranger than fiction

With massive change on the horizon for healthcare, diagnostics has a key role to play in the future.

We met. We learnt. We discovered

Scientific Laboratory Show a “great success”

Top